States
What each state spends on prescription drugs through Medicare and Medicaid, how its doctors prescribe compared with the rest of the country, and the life-science companies raising money there.
Drug spending, prescribing and life-science activity in each state: Medicare Part D (2024), Medicaid (2025), fundraising and attorney general cases.
Every State
Sort by spending or opioid share; each opens its page.| Alabama | $5.3B | $1.0B | 5.2% |
| Alaska | $396M | $213M | 3.9% |
| Arizona | $5.4B | $2.1B | 4.1% |
| Arkansas | $2.7B | $499M | 4.7% |
| California | $27.3B | $18.3B | 3.3% |
| Colorado | $3.7B | $1.6B | 4.7% |
| Connecticut | $4.1B | $2.0B | 2.8% |
| Delaware | $941M | $273M | 3.7% |
| District of Columbia | $716M | $325M | 2.7% |
| Florida | $21.5B | $3.3B | 3.5% |
| Georgia | $9.1B | $1.3B | 4.3% |
| Hawaii | $997M | $264M | 2.8% |
| Idaho | $1.3B | $590M | 5.0% |
| Illinois | $9.6B | $3.3B | 3.2% |
| Indiana | $6.5B | $2.9B | 4.3% |
| Iowa | $2.4B | $1.0B | 3.2% |
| Kansas | $2.4B | $400M | 4.1% |
| Kentucky | $5.0B | $2.8B | 4.5% |
| Louisiana | $4.8B | $2.5B | 4.2% |
| Maine | $1.4B | $535M | 3.3% |
| Maryland | $4.5B | $1.7B | 3.8% |
| Massachusetts | $7.6B | $2.6B | 2.7% |
| Michigan | $9.8B | $4.2B | 4.2% |
| Minnesota | $4.3B | $1.6B | 3.1% |
| Mississippi | $2.7B | $595M | 4.1% |
| Missouri | $6.0B | $2.0B | 3.9% |
| Montana | $704M | $356M | 4.4% |
| Nebraska | $1.6B | $504M | 3.4% |
| Nevada | $2.0B | $870M | 4.7% |
| New Hampshire | $1.1B | $272M | 3.0% |
| New Jersey | $8.0B | $2.0B | 2.4% |
| New Mexico | $1.3B | $674M | 3.9% |
| New York | $22.9B | $12.7B | 2.1% |
| North Carolina | $10.2B | $4.7B | 4.2% |
| North Dakota | $549M | $105M | 3.0% |
| Ohio | $11.3B | $4.8B | 3.3% |
| Oklahoma | $3.3B | $1.0B | 4.8% |
| Oregon | $3.0B | $1.0B | 4.7% |
| Pennsylvania | $14.0B | $5.4B | 2.9% |
| Puerto Rico | $3.1B | $1.4B | 0.6% |
| Rhode Island | $953M | $306M | 2.4% |
| South Carolina | $5.2B | $964M | 4.0% |
| South Dakota | $699M | $282M | 3.5% |
| Tennessee | $7.1B | $1.6B | 4.4% |
| Texas | $20.1B | $3.7B | 3.6% |
| Utah | $1.6B | $517M | 5.1% |
| Vermont | $541M | $178M | 3.2% |
| Virginia | $6.1B | $2.5B | 3.3% |
| Washington | $4.8B | $1.8B | 4.3% |
| West Virginia | $1.9B | $886M | 3.2% |
| Wisconsin | $4.9B | $2.1B | 3.3% |
| Wyoming | $259M | $43M | 4.6% |
Amounts are before manufacturer rebates. Refreshed weekly. CMS Medicare Part D Prescribers by Geography; CMS State Drug Utilization Data